Clinical Trial Update: Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating a triplet regimen of liposomal irinotecan, S-1, and oxaliplatin in advanced pancreatic cancer (pancreatic ductal adenocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Liposomal irinotecan (Onivyde) (irinotecan liposome)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Asan Medical Center | Conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED